Literature DB >> 27558746

It's time to take psilocybin seriously as a possible treatment for substance use disorders.

Michael P Bogenschutz1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27558746     DOI： 10.1080/00952990.2016.1200060

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN： 0095-2990            Impact factor:   3.829


× No keyword cloud information.
  4 in total

1.  Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder.

Authors:  Deepak Cyril D'Souza; Shariful A Syed; L Taylor Flynn; Hamideh Safi-Aghdam; Nicholas V Cozzi; Mohini Ranganathan
Journal:  Neuropsychopharmacology       Date:  2022-06-03       Impact factor: 8.294

2.  Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.

Authors:  Christopher S Stauffer; Brian T Anderson; Kile M Ortigo; Joshua Woolley
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-09

3.  Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine.

Authors:  David M O'Shaughnessy; Ilana Berlowitz; Robin Rodd; Zoltán Sarnyai; Frances Quirk
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-25

Review 4.  Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Authors:  Krista M Lisdahl; Kenneth J Sher; Kevin P Conway; Raul Gonzalez; Sarah W Feldstein Ewing; Sara Jo Nixon; Susan Tapert; Hauke Bartsch; Rita Z Goldstein; Mary Heitzeg
Journal:  Dev Cogn Neurosci       Date:  2018-02-21       Impact factor: 5.811
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.